If you struggle with thinning hair, here's what's causing it. Try one of these thinning hair treatments, including Rogaine, ...

When applied to your lash line on a daily basis, Latisse promotes the growth of lashes by extending the growth phase of the ...

FDA approves Zepbound for sleep apnea in adults. Zepbound aids weight loss with diet and exercise. Possible side effects include nausea and thyroid issues. The US Food and Drug Administration (FDA) ...

The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, the drugmaker Eli Lilly said Friday. The decision ...

WASHINGTON, Dec 21 — US regulators yesterday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans.

The FDA has expanded the approval of Eli Lillys obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication approved ...

WASHINGTON, D.C. — US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans. "This ...

NEW YORK – The US Food and Drug Administration on Friday granted accelerated approval to Pfizer's Braftovi (encorafenib) plus Eli Lilly's Erbitux (cetuximab) with chemotherapy for patients with newly ...

Use code "MARYAM" for a discount at <a href="https://glnk.io/yp7x/maryam-hampton">https://glnk.io/yp7x/maryam-hampton</a> #vegamour @vegamour SHOP my Natural Hair ...

The company has received US Food and Drug Administration approval for its drug Ryoncil, in a stunning turnaround from a year ago, when the same drug tanked the share price. It is a stunning ...

Lupin Share Price: Indian pharmaceutical giant Lupin gained US FDA approval for its generic version of Gilead Sciences' HIV drug Descovy. This win grants Lupin 180 days of shared exclusivity in the US ...

History is made as the FDA approves Mesoblast’s Ryoncil for paediatric graft-versus-host disease LTR Pharma firms up a compact with the Mens Health Downunder network The paperwork’s in! Orthocell ...